BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35226171)

  • 1. Tissue levels of suppressor of cytokine signaling-3 (SOCS-3) in mycosis fungoides.
    Nada HR; Rashed LA; Salman OO; Abdallah NMA; Abdelhady MM
    Arch Dermatol Res; 2023 Mar; 315(2):165-171. PubMed ID: 35226171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In the skin lesions of patients with mycosis fungoides, the number of MRGPRX2-expressing cells is increased and correlates with mast cell numbers.
    Hu M; Pyatilova P; Altrichter S; Sheng C; Liu N; Terhorst-Molawi D; Lohse K; Ginter K; Puhl V; Maurer M; Metz M; Kolkhir P
    Front Immunol; 2023; 14():1197821. PubMed ID: 38022672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stratum corneum cytokine levels in mycosis fungoides.
    Nguyen AL; Kezic S; Vermeer M; Quint K; Slieker R; van Doorn R; Rustemeyer T
    Exp Dermatol; 2023 Feb; 32(2):214-219. PubMed ID: 36302170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the tissue and serum levels of IL-35 in Mycosis fungoides: a case-control study.
    Elmasry MF; Obaid YA; El-Samanoudy SI; Nour ZA; Doss SS
    Arch Dermatol Res; 2024 Jun; 316(7):349. PubMed ID: 38850434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides.
    Kakinuma T; Sugaya M; Nakamura K; Kaneko F; Wakugawa M; Matsushima K; Tamaki K
    J Am Acad Dermatol; 2003 Jan; 48(1):23-30. PubMed ID: 12522366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor (TLR)7 expression in mycosis fungoides and psoriasis: a case-control study.
    El Tawdy AM; Amin IM; Abdel Hay RM; Hassan AS; Gad ZS; Rashed LA
    Clin Exp Dermatol; 2017 Mar; 42(2):172-177. PubMed ID: 28054376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides.
    Wieser I; Wang C; Alberti-Violetti S; Lyons G; Tran C; Talpur R; Duvic M
    Arch Dermatol Res; 2017 Aug; 309(6):453-459. PubMed ID: 28516243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cells and tryptase are linked to itch and disease severity in mycosis fungoides: Results of a pilot study.
    Terhorst-Molawi D; Lohse K; Ginter K; Puhl V; Metz M; Hu M; Maurer M; Altrichter S
    Front Immunol; 2022; 13():930979. PubMed ID: 36032167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.
    Brender C; Nielsen M; Kaltoft K; Mikkelsen G; Zhang Q; Wasik M; Billestrup N; Odum N
    Blood; 2001 Feb; 97(4):1056-62. PubMed ID: 11159537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
    Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
    J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of itching in mycosis fungoides: grade of itching correlates with eosinophil infiltration and kallikrein 5 expression.
    Shimizu K; Andoh T; Makino T; Yoshihisa Y; Mizawa M; Shimizu T
    Eur J Dermatol; 2019 Jun; 29(3):268-273. PubMed ID: 31389785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of serum and tissue level of interleukin-15 (IL-15) and IL-15 receptor alpha (IL-15Rα) in mycosis fungoides before and after phototherapy: An interventional cohort study.
    Mogawer RM; Youssef R; Helmy K; Emad N; Shaker O; Orabi S
    Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12938. PubMed ID: 38157308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation of mycosis fungoides: T-cell receptor beta gene analysis demonstrates a common clonal origin for plaque-type mycosis fungoides and CD30+ large-cell lymphoma.
    Wood GS; Bahler DW; Hoppe RT; Warnke RA; Sklar JL; Levy R
    J Invest Dermatol; 1993 Sep; 101(3):296-300. PubMed ID: 8396607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressed microRNA-195-5p expression in mycosis fungoides promotes tumor cell proliferation.
    Rittig AH; Johansen C; Celis P; Odum N; Litman T; Woetmann A; Lindahl LM; Iversen L
    Exp Dermatol; 2021 Aug; 30(8):1141-1149. PubMed ID: 32492224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR7 expression correlates with subcutaneous involvement in mycosis fungoides skin lesions and promotes migration of mycosis fungoides cells (MyLa) through mTOR activation.
    Hu SC; Lin CL; Hong CH; Yu HS; Chen GS; Lee CH
    J Dermatol Sci; 2014 Apr; 74(1):31-8. PubMed ID: 24411580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-infiltrating and circulating granulocytic myeloid-derived suppressor cells correlate with disease activity and adverse clinical outcomes in mycosis fungoides.
    Argyropoulos KV; Pulitzer M; Perez S; Korkolopoulou P; Angelopoulou M; Baxevanis C; Palomba ML; Siakantaris M
    Clin Transl Oncol; 2020 Jul; 22(7):1059-1066. PubMed ID: 31696413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides.
    de Masson A; O'Malley JT; Elco CP; Garcia SS; Divito SJ; Lowry EL; Tawa M; Fisher DC; Devlin PM; Teague JE; Leboeuf NR; Kirsch IR; Robins H; Clark RA; Kupper TS
    Sci Transl Med; 2018 May; 10(440):. PubMed ID: 29743350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile.
    Saed G; Fivenson DP; Naidu Y; Nickoloff BJ
    J Invest Dermatol; 1994 Jul; 103(1):29-33. PubMed ID: 8027577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.